Literature DB >> 24647214

Effects of universal screening for depression among middle-aged adults in a community with a high suicide rate.

Hirofumi Oyama1, Tomoe Sakashita.   

Abstract

We examined the effect of a community-based screening program on depression in middle-aged individuals. Ten subdistricts constituting a rural township (2400 inhabitants aged 40-64 years) in northern Japan with a high suicide rate were randomly assigned to intervention (four) and control (six) groups. A 2-year depression-screening program entailing identification and subsequent care support was offered to adults aged 40 to 64 years in the intervention group, accompanied by 4-year ongoing dissemination of educational information in both groups. Change in depressive symptom prevalence was assessed through before-and-after cross-sectional surveys using the Center for Epidemiologic Studies-Depression Scale. Of the 900 targeted individuals, 49.2% participated in the screening. Comparison of data from these surveys after controlling for district-level clustering indicated a greater difference in prevalence between baseline and 5-year follow-up in the intervention group than that in the control. Universal screening and subsequent support seem effective to decrease depressive symptom prevalence among middle-aged individuals in a community setting.

Entities:  

Mesh:

Year:  2014        PMID: 24647214     DOI: 10.1097/NMD.0000000000000119

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  A Mobile App for Stress Management in Middle-Aged Men and Women (Calm): Feasibility Randomized Controlled Trial.

Authors:  Breanne Laird; Megan Puzia; Linda Larkey; Diane Ehlers; Jennifer Huberty
Journal:  JMIR Form Res       Date:  2022-05-24

2.  The reliability, validity and screening effect of the happiness index scale among inpatients in a general hospital.

Authors:  Yizhong Shen; Shuai Yuan; Jingwen Liu; Bin Sun; Zilin Chen; Lijiao Zheng; Lihao Chen; Hanwei Chen; Huiqiang Feng; Hongbo He
Journal:  BMC Psychiatry       Date:  2022-09-09       Impact factor: 4.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.